Investigation Report on China Dydrogesterone Market, 2010-2019

September 2015 | 20 pages | ID: I78E501FBFDEN
China Research and Intelligence Co., Ltd.

Abstracts

Description

According to statistics, over 90% of Chinese adult women suffer from different kinds of gynecological conditions to different degrees. And for married urban women, the TOP5 gynecological disorders are genital tract infections (42.9%), menstrual disorder (34.5%), dysmenorrheal (15.5%), pelvic tumor (3.9%) and genital deformity (1.1%). According to Infertility in China, one in eight couples suffers from infertility whose incidence rose from 1-2% in the 1970s to 10-15% in 2014. And it is estimated that 12.5% of women at childbearing age i.e. over 40 million people in China suffer from infertility. 25-37% of infertility is caused by women and over 30% of infertility patients are white collars with high income. According to experts, infertility will become the third health killer after cardiovascular disease and tumor.

As a new generation of progesterone, dydrogesterone of Abbott Biologicals B.V. (Netherland) has been marketed in over 150 countries since its debut in 1961. And it has got the recognition of Chinese obstetricians since it entered China in Apr. 2004.

According to CRI’s market survey, dydrogesterone develops fast after entering China with sales value in sample hospitals rising from less than 4 million in 2005 to over 100 million in 2014 and CAGR during this period reaching 50%. Currently, only dydrogesterone of Abbott Biologicals B.V. (Netherland) is available in the Chinese market. As the incidence of gynecological conditions stays high, dydrogesterone enjoys great market potential with its efficacy. Dydrogesterone market in China is expected to grow in future and it is possible that newcomers might appear too.

Readers can get at least the following information through this report:

• market size of dydrogesterone in China
• competitive landscape of dydrogesterone market in China
• price of dydrogesterone made by different enterprises in China
• market outlook of dydrogesterone in China

The author suggests the following groups of people purchase this report:

• Pharmaceutical Manufacturers
• investors/research institutions interested in Chinese medicine market
• -any interest in Chinese medicine market, please contact CRI for customized survey service

Contents

1 RELATED CONCEPTS OF DYDROGESTERONE

1.1 Indication
1.2 Sales in Global Market

2 MARKET PROFILE OF DYDROGESTERONE IN CHINA

2.1 Patent and Approval Information of Dydrogesterone in China
2.2 Major Manufacturers
2.3 Market Size

3 SURVEY ON DYDROGESTERONE SALES IN CHINA, 2010-2014

3.1 Sales Value
  3.1.1 Overall Sales Value
  3.1.2 Sales Value by Regions
3.2 Sales Volume
  3.2.1 Overall Sales Volume
  3.2.2 Sales Volume by Regions

4 SURVEY ON MARKET SHARE OF MAJOR DYDROGESTERONE MANUFACTURERS IN CHINA, 2010-2014

4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 SURVEY ON DOSAGE FORMS OF DYDROGESTERONE IN CHINA, 2010-2014

6 REFERENCE PRICE OF DYDROGESTERONE IN CHINESE HOSPITALS IN 2014

7 MAJOR MANUFACTURERS OF DYDROGESTERONE IN CHINESE MARKET, 2010-2014

8 MARKET OUTLOOK OF DYDROGESTERONE IN CHINA, 2015-2019

8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

TABLE OF SELECTED CHARTS

Chart Patent of Dydrogesterone in China
Chart Approval Information of Dydrogesterone in China
Chart Dydrogesterone Sales in China
Chart Sales Value of Dydrogesterone in China, 2010-2014
Chart Sales Value of Dydrogesterone in some Regions in China, 2010-2014
Chart Sales Volume of Dydrogesterone in China, 2010-2014
Chart Sales Volume of Dydrogesterone in Some Regions in China, 2010-2014
Chart Sales Value and Market Share of Dydrogesterone Made by Abbott Biologicals B.V. (Netherland) in China, 2010-2014
Chart Market Share of TOP1 Dydrogesterone Manufacturer for Sales Volume in China, 2010-2014
Chart Price of Dydrogesterone Made by Abbott Biologicals B.V. (Netherland) in Some Chinese Cities in 2014